Table 5.
Ref. | Year | Category | Disease (:control) | AUC | Accuracy | Sensitivity | Specificity | Sample No. | Control No. |
Di Cagno et al[46] | 2009 | Celiac disease | Treated celiac disease | - | - | - | - | 7 | 7 |
Di Cagno et al[46] | 2009 | Celiac disease | Untreated celiac disease | - | - | - | - | 7 | 7 |
Di Cagno et al[46] | 2009 | Celiac disease | Treated:Untreated celiac disease | - | - | - | - | 7 | 7 |
Garner et al[73] | 2009 | Enterocolitis | Necrotizing enterocolitis | - | - | - | - | 6 | 7 |
Raman et al[74] | 2013 | Liver disease | NAFLD | - | - | - | - | 30 | 30 |
Bjarnason et al[75] | 2009 | Liver disease | NAFLD | - | - | - | - | 7 | 9 |
Covington et al[76] | 2012 | Radiation toxicity | Low GI pelvic radiation toxicity | - | 90% | - | - | 10 | 11 |
Covington et al[76] | 2012 | Radiation toxicity | High GI pelvic radiation toxicity | - | 90% | - | - | 11 | 12 |
Covington et al[76] | 2012 | Radiation toxicity | Low GI pelvic radiation toxicity | - | 80% | - | - | 8 | 11 |
Covington et al[76] | 2012 | Radiation toxicity | High GI pelvic radiation toxicity | - | 80% | - | - | 10 | 12 |
If no control is specified, the comparison is against a healthy control. NAFLD: Nonalcoholic fatty liver disease; AUC: Area under the curve; GI: Gastrointestinal.